Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Jullien

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
Infectious Diseases Now|June 20, 2026
Antibiotic penetration in the male urinary tract: a critical review of pharmacokinetic and pharmacodynamic evidenceAntoine Hamon, Vincent Jullien, Vincent Cattoir, et al.
BMJ Open|January 26, 2019
Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trialGeraldine Favrais, Moreno Ursino, Catherine Mouchel, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
The Pediatric Infectious Disease Journal|September 29, 2007
Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovirAndrea Papaleo, Josiane Warszawski, Rémi Salomon, et al.
European Journal of Clinical Pharmacology|March 23, 2018
A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsyChristelle Rodrigues, Stéphanie Chhun, Catherine Chiron, et al.
Drug Metabolism Reviews|November 5, 2015
A review of potential pharmacogenetic effects on catecholamine responsesMarwa Ounissi, Aida Benkirane, Eugene Dempsey, et al.
The Journal of Infectious Diseases|April 28, 2009
Does HIV-1 subtype D have a higher risk of vertical transmission than other HIV subtypes?Anne Krivine, Odile Launay, Ghislaine Firtion, et al.
Clinical Pharmacokinetics|December 17, 2009
Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug ActionCaroline Bazzoli, Vincent Jullien, Clotilde Le Tiec, et al.
Clinical Pharmacokinetics|December 16, 2014
Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic AcidVincent Jullien, Stéphanie Chhun, Elisabeth Rey, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Designing a Pediatric Study for an Antimalarial Drug by Using Information from AdultsCaroline Petit, Vincent Jullien, Adeline Samson, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Infectious Diseases Now|June 20, 2026
Antibiotic penetration in the male urinary tract: a critical review of pharmacokinetic and pharmacodynamic evidenceAntoine Hamon, Vincent Jullien, Vincent Cattoir, et al.
BMJ Open|January 26, 2019
Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trialGeraldine Favrais, Moreno Ursino, Catherine Mouchel, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
The Pediatric Infectious Disease Journal|September 29, 2007
Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovirAndrea Papaleo, Josiane Warszawski, Rémi Salomon, et al.
European Journal of Clinical Pharmacology|March 23, 2018
A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsyChristelle Rodrigues, Stéphanie Chhun, Catherine Chiron, et al.
Drug Metabolism Reviews|November 5, 2015
A review of potential pharmacogenetic effects on catecholamine responsesMarwa Ounissi, Aida Benkirane, Eugene Dempsey, et al.
The Journal of Infectious Diseases|April 28, 2009
Does HIV-1 subtype D have a higher risk of vertical transmission than other HIV subtypes?Anne Krivine, Odile Launay, Ghislaine Firtion, et al.
Clinical Pharmacokinetics|December 17, 2009
Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug ActionCaroline Bazzoli, Vincent Jullien, Clotilde Le Tiec, et al.
Clinical Pharmacokinetics|December 16, 2014
Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic AcidVincent Jullien, Stéphanie Chhun, Elisabeth Rey, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Designing a Pediatric Study for an Antimalarial Drug by Using Information from AdultsCaroline Petit, Vincent Jullien, Adeline Samson, et al.
Pageof 13